From: Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
All | Cases diagnosed <2 years | Cases diagnosed ≥2 years | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AUC | Spe | Sen | Acc | AUC | Spe | Sen | Acc | AUC | Spe | Sen | Acc | |
AFPa | 73 | 65.3 | 71.9 | 67.5 | 81 | 79 | 77.3 | 78.5 | 71 | 60.9 | 74 | 65.3 |
Liver function scoreb | 80 | 84.7 | 70.2 | 79.8 | 79 | 88.4 | 68.2 | 81.5 | 80 | 83.8 | 70.6 | 79.3 |
O-PLS scorec | 85 | 81.5 | 71.1 | 78.1 | 93 | 83.7 | 86.4 | 84.6 | 79 | 74.9 | 68.5 | 72.7 |
O-PLS CV statusd | 74 | 68 | 68.4 | 68.1 | 82 | 100 | 63.6 | 87.7 | 71 | 68.7 | 67.4 | 68.3 |
O-PLS CV status + AFPe | 75 | 80.6 | 75.4 | 78.9 | 82 | 100 | 63.6 | 87.7 | 73 | 70.9 | 70.6 | 70.8 |
O-PLS CV status + liver scoref | 82 | 68 | 68.4 | 68.1 | 84 | 86 | 77.3 | 83 | 80 | 83.8 | 70.7 | 79.3 |